PageSourceSearch

https://magnusmedclub.com/about-us

html magnusmedclub.com collected 2026-10-08 08:51:41 UTC 55,083 bytes, 1,041 lines download raw bytes

1<!DOCTYPE html>
2<html lang="en">
3
4<head>
5    <!-- Google tag (gtag.js) -->
vendor: 68 bytes, lines 5-6
5
6    <script async src="https://www.googletagmanager.com/gtag/js?id=
6G-VQ4MJTJYQ5
vendor: 12 bytes, line 6
6"></script> 
6<script> 
vendor: 127 bytes, line 6
6window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', '
6G-VQ4MJTJYQ5
vendor: 4 bytes, line 6
6'); 
6</script>
6
7    <meta name="viewport" content="width=device-width, initial-scale=1" />
8    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
9    <link rel="icon" type="image/png" href="https://magnusmedclub.com/assets-front/images/favicon.png" />
10    <!-- Document title -->
11          <title>About Magnus Med Club | Magnus Med Club LLC |  Ohio, USA</title>
12    <meta name="keywords" content="Magnus med club, magnus med club llc, magnus med, open access publisher, magnus med club journals, magnus medical journals, magnus clinical journals, mmc"/>
13    <meta name="description" content="Magnus Med Club LLC incorporated in ohio, usa offers open access publications having free access to magnus med club journals in medical and clinical domains."/>
14    <!-- Stylesheets & Fonts -->
15	 <link href="https://fonts.googleapis.com/css?family=Montserrat:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet">
16
17    
18     <!-- ========== Start Stylesheet ========== -->
19    <link href="https://magnusmedclub.com/assets-front/css/bootstrap.min.css" rel="stylesheet" />
20    <link href="https://magnusmedclub.com/assets-front/css/font-awesome.min.css" rel="stylesheet" />
21
22    <link href="https://magnusmedclub.com/assets-front/css/style.css" rel="stylesheet">
23    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
24
25    <style>
26		.border8 {
27		    border: 3px #000 solid;
28		}
29	</style>
30    
31<!-- Schema Code -->
32<script type="application/ld+json">
33
34{
35
36  "@context": "https://schema.org",
37
38  "@type": "Organization",
39
40  "name": "Magnus Med Club LLC",
41
42  "alternateName": "Magnus Med",
43
44  "url": "https://www.magnusmedclub.com/",
45
46  "logo": "https://www.magnusmedclub.com/assets-front/images/mmc_logo.png",
47
48  "sameAs": [
49
50    "https://www.facebook.com/MagnusMedClubLLC/",
51
52    "https://twitter.com/MagnusMedClub"
53
54  ]
55
56}
57
58</script>
58    
59
60     
61</head>
62<body class="no-page-loader">
63    <!-- Wrapper -->
64    
65<div class="topbar">
66	<div class="container">
67	<div class="row">
68	<div class="col-md-6 col-sm-6 col-xs-12">
69	<div class="topbarlists">
70	<ul>
71
72<li><a href="https://magnusmedclub.com/about-us" title="About Us">About</a></li>
73	<li><a href="https://magnusmedclub.com/instructions" title="Instructions">Instructions</a></li>
74	<li><a href="https://magnusmedclub.com/contact-us" title="Contact us">Contact us</a></li> 
75	</ul>
76	</div>
77	</div>
78
79	<div class="col-md-6 col-sm-6 col-xs-12">
80	<div class="socialicons">
81	<a href="https://www.facebook.com" target="_blank" title="Face Book" class="fa fa-facebook"></a>
82    <a href="https://x.com/magnus_med1203" target="_blank" title="Twitter"class="fa fa-twitter"></a>
83	<!-- <div class="social">
84                            
85    </div> -->
86	</div>
87	</div>
88	</div>
89	</div>
90	</div>   
91        <!-- LOGO TEXT -->
92		
93
94<div class="logo">
95	<div class="container">
96	    <a href="https://magnusmedclub.com/"> <img src="https://magnusmedclub.com/assets-front/images/mmc_logo.png"> </a>
97        <!-- <a href="https://magnusmedclub.com/" title="MAGNUS MED CLUB">
98            <h1>MAGNUS MED CLUB</h1>
99        </a> --> 
100	
101	</div>
102	</div>		<!-- end: LOGO TEXT -->
103    	<header id="header" class="header header-transparent nav-border">
104        <!-- Start Navigation -->
105        <nav class="navbar navbar-default navbar-sticky bootsnav">
106            <div class="container">
107                <!-- Start Header Navigation -->
108                <div class="navbar-header">
109                    <button type="button" class="navbar-toggle" data-toggle="collapse" class="navbar-toggle navbar-toggler ml-auto" data-target="#navbar-menu">
110                        <i class="fa fa-bars"></i>
111                    </button>
112                    
113                </div>
114                <!-- End Header Navigation -->
115                <!-- Collect the nav links, forms, and other content for toggling -->
116                <div class="collapse navbar-collapse" id="navbar-menu">
117                    <ul class="nav navbar-nav navbar-left" data-in="fadeInDown" data-out="fadeOutUp">
118						
119                                
120                                                                    <li class="">
121                                    <a href="https://magnusmedclub.com/home" target="" title="Home">Home</a>
122                                                                    
123                                </li>
124                                
125                                                                    <li class=" active">
126                                    <a href="https://magnusmedclub.com/about-us" target="" title="About Us">About Us</a>
127                                                                    
128                                </li>
129                                
130                                                                    <li class="">
131                                    <a href="https://magnusmedclub.com/journals" target="" title="Journals">Journals</a>
132                                                                    
133                                </li>
134                                
135                                                                    <li class="">
136                                    <a href="https://magnusmedclub.com/submit-manuscript" target="" title="Submit Manuscript">Submit Manuscript</a>
137                                                                    
138                                </li>
139                                
140                                                                    <li class="">
141                                    <a href="https://magnusmedclub.com/instructions" target="" title="Instructions">Instructions</a>
142                                                                    
143                                </li>
144                                
145                                                                    <li class="">
146                                    <a href="https://magnusmedclub.com/contact-us" target="" title="Contact us">Contact us</a>
147                                                                    
148                                </li>
149                                
150                                                                   
151                                  
152                           
153                    </ul>
154                </div><!-- /.navbar-collapse -->
155            </div>
156        </nav>
157        <!-- End Navigation -->
158    </header>
159
160
161
162
163
164
165
166
167		<!--END: HEADER-->
168    
169
170        
171         <!-- container -->
172    
173    <div class="container">
174    	<div class="row m-t-20 m-b-20">
175	<!-- Left section -->         
176        	<div class="col-md-9">
177			
178				
179				<!-- articles start -->
180				
181				<div class="journalarticlesheading">
182				<h3>About Us</h3>
183				</div>
184   
185               
186                <div class="r-mid-box p-t-20">
187                 
188            	<div class="row">
189            		<div class="col-md-12">
190							<p>Magnus Med Club (MMC) helps researchers to publish new discoveries in the various fields of research which leads to the development of the scientific community. Our journals are open access and constantly updated to keep the knowledge flowing. Open Access to scientific discoveries and ideas is an approach to propagate knowledge worldwide.</p>
191
192<h4>Who We Are</h4>
193
194<p>We are a team committed to present innovative research work. Magnus Med Club wants to provide the quality end of research papers to scientists, researchers in order to maintain the standards led by the publication ethics.</p>
195
196<h4>Vision</h4>
197
198<p>We aim to provide the best literature for the readers among the other publications. We utilize world-class technology, resources to maintain the high-end quality platform for the authors.</p>
199
200<h4>Mission</h4>
201
202<p>Our Mission is to promote research, create Value-based Knowledge and best global practices in sectors of the scientific field. Magnus Med Club anticipates standards to bring excellent quality journals in all fields.
202</p>
203						<div class="row m-t-40">
204             
205        </div>	    
206                	</div>
207            	</div>
208               
209		
210                
211				<div class="journalarticlesheading">
212				<h3>Articles </h3>
213				</div>
214				<div class="row">
215			
216				
217				        				<div class="col-md-6">
218				<div class="journalarticles fix_height">
219                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
220		
221				<a href="https://www.oncogen.org/full-text/crispr-cas9-based-editing-of-cdk4-p107-and-tgf-1-in-human-breast-and-lung-cancer-cells" target="_blank" title="CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells"><h3>CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells</h3></a>
222				
223                <p>
224				Hussein Sabit<sup>1*</sup>, Doha Alaa<sup>2</sup>, [....]                
225                </p>
226                  <ul class="infolinks">
227              
228				<li><a href="https://www.oncogen.org/full-text/crispr-cas9-based-editing-of-cdk4-p107-and-tgf-1-in-human-breast-and-lung-cancer-cells" target="_blank" title="CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
229                
230                    
231                    
232                        <li>
233                <a href="https://www.oncogen.org/full-text/crispr-cas9-based-editing-of-cdk4-p107-and-tgf-1-in-human-breast-and-lung-cancer-cells" target="_blank" title="CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
234                </li>
235                    
236                        
237                    
238               
239                </ul>
240				</div>
241				</div>
242                				<div class="col-md-6">
243				<div class="journalarticles fix_height">
244                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
245		
246				<a href="https://www.oncogen.org/full-text/palliative-systemic-treatment-of-advanced-merkel-cell-carcinoma-in-the-pre-immunotherapy-era-a-retrospective-single-center-analysis-of-patients-with-an-orphan-neuroendocrine-malignancy" target="_blank" title="Palliative Systemic Treatment Of Advanced Merkel Cell Carcinoma In The Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis Of Patients With An Orphan Neuroendocrine Malignancy"><h3>Palliative Systemic Treatment Of Advanced Merkel Cell Carcinoma In The Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis Of Patients With An Orphan Neuroendocrine Malignancy</h3></a>
247				
248                <p>
249				Patrick Sch&ouml;ffski<sup>*</sup>, Gitte Moors, P [....]                
250                </p>
251                  <ul class="infolinks">
252              
253				<li><a href="https://www.oncogen.org/full-text/palliative-systemic-treatment-of-advanced-merkel-cell-carcinoma-in-the-pre-immunotherapy-era-a-retrospective-single-center-analysis-of-patients-with-an-orphan-neuroendocrine-malignancy" target="_blank" title="Palliative Systemic Treatment Of Advanced Merkel Cell Carcinoma In The Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis Of Patients With An Orphan Neuroendocrine Malignancy"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
254                
255                    
256                    
257                        <li>
258                <a href="https://www.oncogen.org/full-text/palliative-systemic-treatment-of-advanced-merkel-cell-carcinoma-in-the-pre-immunotherapy-era-a-retrospective-single-center-analysis-of-patients-with-an-orphan-neuroendocrine-malignancy" target="_blank" title="Palliative Systemic Treatment Of Advanced Merkel Cell Carcinoma In The Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis Of Patients With An Orphan Neuroendocrine Malignancy" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
259                </li>
260                    
261                        
262                    
263               
264                </ul>
265				</div>
266				</div>
267                				<div class="col-md-6">
268				<div class="journalarticles fix_height">
269                <div class="btn btn-sm btn-default m-b-10">Mini Review</div>
270		
271				<a href="https://www.oncogen.org/full-text/the-suppression-of-prolactin-is-required-for-the-treatment-of-advanced-prostate-cancer" target="_blank" title="The Suppression Of Prolactin Is Required For The Treatment Of Advanced Prostate Cancer"><h3>The Suppression Of Prolactin Is Required For The Treatment Of Advanced Prostate Cancer</h3></a>
272				
273                <p>
274				Leslie C Costello</p>
275                
276                </p>
277                  <ul class="infolinks">
278              
279				<li><a href="https://www.oncogen.org/full-text/the-suppression-of-prolactin-is-required-for-the-treatment-of-advanced-prostate-cancer" target="_blank" title="The Suppression Of Prolactin Is Required For The Treatment Of Advanced Prostate Cancer"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
280                
281                    
282                    
283                        <li>
284                <a href="https://www.oncogen.org/full-text/the-suppression-of-prolactin-is-required-for-the-treatment-of-advanced-prostate-cancer" target="_blank" title="The Suppression Of Prolactin Is Required For The Treatment Of Advanced Prostate Cancer" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
285                </li>
286                    
287                        
288                    
289               
290                </ul>
291				</div>
292				</div>
293                				<div class="col-md-6">
294				<div class="journalarticles fix_height">
295                <div class="btn btn-sm btn-default m-b-10">
295Review Article</div>
296		
297				<a href="https://www.oncogen.org/full-text/post-translational-modifications-ptms-from-a-cancer-perspective-an-overview" target="_blank" title="Post-Translational Modifications (PTMs), From A Cancer Perspective: An Overview"><h3>Post-Translational Modifications (PTMs), From A Cancer Perspective: An Overview</h3></a>
298				
299                <p>
300				B Sharan Sharma<sup>1,2</sup>, Vaishna Prabhakaran [....]                
301                </p>
302                  <ul class="infolinks">
303              
304				<li><a href="https://www.oncogen.org/full-text/post-translational-modifications-ptms-from-a-cancer-perspective-an-overview" target="_blank" title="Post-Translational Modifications (PTMs), From A Cancer Perspective: An Overview"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
305                
306                    
307                    
308                        <li>
309                <a href="https://www.oncogen.org/full-text/post-translational-modifications-ptms-from-a-cancer-perspective-an-overview" target="_blank" title="Post-Translational Modifications (PTMs), From A Cancer Perspective: An Overview" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
310                </li>
311                    
312                        
313                    
314               
315                </ul>
316				</div>
317				</div>
318                				<div class="col-md-6">
319				<div class="journalarticles fix_height">
320                <div class="btn btn-sm btn-default m-b-10">Case Report</div>
321		
322				<a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma"><h3>Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma</h3></a>
323				
324                <p>
325				Elise F Nassif*, Alexandre Arsene-Henry, Youlia M  [....]                
326                </p>
327                  <ul class="infolinks">
328              
329				<li><a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
330                
331                    
332                    
333                        <li>
334                <a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
335                </li>
336                    
337                        
338                    
339               
340                </ul>
341				</div>
342				</div>
343                				<div class="col-md-6">
344				<div class="journalarticles fix_height">
345                <div class="btn btn-sm btn-default m-b-10">Review Article</div>
346		
347				<a href="https://www.oncogen.org/full-text/single-subject-studies-in-prostate-cancer-how-graphing-psa-test-results-and-testosterone-levels-using-process-behavior-and-celeration-charts-can-provide-insight-and-guide-clinical-decisions" target="_blank" title="Single Subject Studies In Prostate Cancer: How Graphing PSA Test Results And Testosterone Levels Using Process Behavior And Celeration Charts Can Provide Insight And Guide Clinical Decisions"><h3>Single Subject Studies In Prostate Cancer: How Graphing PSA Test Results And Testosterone Levels Using Process Behavior And Celeration Charts Can Provide Insight And Guide Clinical Decisions</h3></a>
348				
349                <p>
350				Al Pfadt*&shy;<sup>1</sup>, Donald J Wheeler<sup>2 [....]                
351                </p>
352                  <ul class="infolinks">
353              
354				<li><a href="https://www.oncogen.org/full-text/single-subject-studies-in-prostate-cancer-how-graphing-psa-test-results-and-testosterone-levels-using-process-behavior-and-celeration-charts-can-provide-insight-and-guide-clinical-decisions" target="_blank" title="Single Subject Studies In Prostate Cancer: How Graphing PSA Test Results And Testosterone Levels Using Process Behavior And Celeration Charts Can Provide Insight And Guide Clinical Decisions"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
355                
356                    
357                    
358                        <li>
359                <a href="https://www.oncogen.org/full-text/single-subject-studies-in-prostate-cancer-how-graphing-psa-test-results-and-testosterone-levels-using-process-behavior-and-celeration-charts-can-provide-insight-and-guide-clinical-decisions" target="_blank" title="Single Subject Studies In Prostate Cancer: How Graphing PSA Test Results And Testosterone Levels Using Process Behavior And Celeration Charts Can Provide Insight And Guide Clinical Decisions" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
360                </li>
361                    
362                        
363                    
364               
365                </ul>
366				</div>
367				</div>
368                				<div class="col-md-6">
369				<div class="journalarticles fix_height">
370                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
371		
372				<a href="https://www.oncogen.org/full-text/a-clinical-study-of-biomarkers-to-predict-the-efficacy-of-cancer-immunotherapy-with-subcutaneous-low-dose-il-2-or-with-immune-checkpoint-inhibitors" target="_blank" title="A Clinical Study Of Biomarkers To Predict The Efficacy Of Cancer Immunotherapy With Subcutaneous Low-Dose Il-2 Or With Immune Checkpoint Inhibitors"><h3>A Clinical Study Of Biomarkers To Predict The Efficacy Of Cancer Immunotherapy With Subcutaneous Low-Dose Il-2 Or With Immune Checkpoint Inhibitors</h3></a>
373				
374                <p>
375				Lissoni P*, Brivio F, Messina G, Vigore L, Rovelli [....]                
376                </p>
377                  <ul class="infolinks">
378              
379				<li><a href="https://www.oncogen.org/full-text/a-clinical-study-of-biomarkers-to-predict-the-efficacy-of-cancer-immunotherapy-with-subcutaneous-low-dose-il-2-or-with-immune-checkpoint-inhibitors" target="_blank" title="A Clinical Study Of Biomarkers To Predict The Efficacy Of Cancer Immunotherapy With Subcutaneous Low-Dose Il-2 Or With Immune Checkpoint Inhibitors"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
380                
381                    
382                    
383                        <li>
384                <a href="https://www.oncogen.org/full-text/a-clinical-study-of-biomarkers-to-predict-the-efficacy-of-cancer-immunotherapy-with-subcutaneous-low-dose-il-2-or-with-immune-checkpoint-inhibitors" target="_blank" title="A Clinical Study Of Biomarkers To Predict The Efficacy Of Cancer Immunotherapy With Subcutaneous Low-Dose Il-2 Or With Immune Checkpoint Inhibitors" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
385                </li>
386                    
387                        
388                    
389               
390                </ul>
391				</div>
392				</div>
393                				<div class="col-md-6">
394				<div class="journalarticles fix_height">
395                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
396		
397				<a href="https://www.oncogen.org/full-text/tumor-infiltrating-lymphocytes-expression-in-stage-iiic-iv-of-high-grade-serous-ovarian-cancer-variation-with-neoadjuvant-chemotherapy-and-prognostic-value" target="_blank" title="Tumor-Infiltrating Lymphocytes Expression In Stage IIIc/IV Of High-Grade Serous Ovarian Cancer: Variation With Neoadjuvant Chemotherapy And Prognostic Value"><h3>
397Tumor-Infiltrating Lymphocytes Expression In Stage IIIc/IV Of High-Grade Serous Ovarian Cancer: Variation With Neoadjuvant Chemotherapy And Prognostic Value</h3></a>
398				
399                <p>
400				K Rojas*<sup>1</sup>, G Prado-Vazquez<sup>2</sup>, [....]                
401                </p>
402                  <ul class="infolinks">
403              
404				<li><a href="https://www.oncogen.org/full-text/tumor-infiltrating-lymphocytes-expression-in-stage-iiic-iv-of-high-grade-serous-ovarian-cancer-variation-with-neoadjuvant-chemotherapy-and-prognostic-value" target="_blank" title="Tumor-Infiltrating Lymphocytes Expression In Stage IIIc/IV Of High-Grade Serous Ovarian Cancer: Variation With Neoadjuvant Chemotherapy And Prognostic Value"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
405                
406                    
407                    
408                        <li>
409                <a href="https://www.oncogen.org/full-text/tumor-infiltrating-lymphocytes-expression-in-stage-iiic-iv-of-high-grade-serous-ovarian-cancer-variation-with-neoadjuvant-chemotherapy-and-prognostic-value" target="_blank" title="Tumor-Infiltrating Lymphocytes Expression In Stage IIIc/IV Of High-Grade Serous Ovarian Cancer: Variation With Neoadjuvant Chemotherapy And Prognostic Value" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
410                </li>
411                    
412                        
413                    
414               
415                </ul>
416				</div>
417				</div>
418                				<div class="col-md-6">
419				<div class="journalarticles fix_height">
420                <div class="btn btn-sm btn-default m-b-10">Opinion Article</div>
421		
422				<a href="https://www.oncogen.org/full-text/triple-hormonal-blockade-adt3-a-patient-s-perspective" target="_blank" title="Triple Hormonal Blockade (ADT3): A Patient’s Perspective"><h3>Triple Hormonal Blockade (ADT3): A Patient’s Perspective</h3></a>
423				
424                <p>
425				Charles Maack*</p>
426                
427                </p>
428                  <ul class="infolinks">
429              
430				<li><a href="https://www.oncogen.org/full-text/triple-hormonal-blockade-adt3-a-patient-s-perspective" target="_blank" title="Triple Hormonal Blockade (ADT3): A Patient’s Perspective"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
431                
432                    
433                    
434                        <li>
435                <a href="https://www.oncogen.org/full-text/triple-hormonal-blockade-adt3-a-patient-s-perspective" target="_blank" title="Triple Hormonal Blockade (ADT3): A Patient’s Perspective" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
436                </li>
437                    
438                        
439                    
440               
441                </ul>
442				</div>
443				</div>
444                				<div class="col-md-6">
445				<div class="journalarticles fix_height">
446                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
447		
448				<a href="https://www.oncogen.org/full-text/removal-of-carcinogenic-arsenic-from-drinking-water-by-the-application-of-ion-exchange-resins" target="_blank" title="Removal Of Carcinogenic Arsenic From Drinking Water By The Application Of Ion Exchange Resins"><h3>Removal Of Carcinogenic Arsenic From Drinking Water By The Application Of Ion Exchange Resins</h3></a>
449				
450                <p>
451				Sevtap Karakurt<sup>1</sup>, Erol Pehlivan<sup>1</ [....]                
452                </p>
453                  <ul class="infolinks">
454              
455				<li><a href="https://www.oncogen.org/full-text/removal-of-carcinogenic-arsenic-from-drinking-water-by-the-application-of-ion-exchange-resins" target="_blank" title="Removal Of Carcinogenic Arsenic From Drinking Water By The Application Of Ion Exchange Resins"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
456                
457                    
458                    
459                        <li>
460                <a href="https://www.oncogen.org/full-text/removal-of-carcinogenic-arsenic-from-drinking-water-by-the-application-of-ion-exchange-resins" target="_blank" title="Removal Of Carcinogenic Arsenic From Drinking Water By The Application Of Ion Exchange Resins" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
461                </li>
462                    
463                        
464                    
465               
466                </ul>
467				</div>
468				</div>
469                				<div class="col-md-6">
470				<div class="journalarticles fix_height">
471                <div class="btn btn-sm btn-default m-b-10">Case Report</div>
472		
473				<a href="https://www.oncogen.org/full-text/breast-metachronous-carcinoma-and-sarcoma-in-a-young-patient-leading-to-the-diagnosis-of-li-fraumeni-syndrome" target="_blank" title="Breast Metachronous Carcinoma and 
473Sarcoma in a Young Patient Leading to the Diagnosis of Li Fraumeni Syndrome"><h3>Breast Metachronous Carcinoma and Sarcoma in a Young Patient Leading to the Diagnosis of Li Fraumeni Syndrome</h3></a>
474				
475                <p>
476				Seidler SJ and Huber DE</p>
477                
478                </p>
479                  <ul class="infolinks">
480              
481				<li><a href="https://www.oncogen.org/full-text/breast-metachronous-carcinoma-and-sarcoma-in-a-young-patient-leading-to-the-diagnosis-of-li-fraumeni-syndrome" target="_blank" title="Breast Metachronous Carcinoma and Sarcoma in a Young Patient Leading to the Diagnosis of Li Fraumeni Syndrome"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
482                
483                    
484                    
485                        <li>
486                <a href="https://www.oncogen.org/full-text/breast-metachronous-carcinoma-and-sarcoma-in-a-young-patient-leading-to-the-diagnosis-of-li-fraumeni-syndrome" target="_blank" title="Breast Metachronous Carcinoma and Sarcoma in a Young Patient Leading to the Diagnosis of Li Fraumeni Syndrome" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
487                </li>
488                    
489                        
490                    
491               
492                </ul>
493				</div>
494				</div>
495                				<div class="col-md-6">
496				<div class="journalarticles fix_height">
497                <div class="btn btn-sm btn-default m-b-10">Case Report</div>
498		
499				<a href="https://www.oncogen.org/full-text/hearing-loss-tinnitus-and-pineal-germinoma-parinaud-dorsal-midbrain-syndrome-revisited" target="_blank" title="Hearing Loss, Tinnitus And Pineal Germinoma: Parinaud Dorsal Midbrain Syndrome Revisited"><h3>Hearing Loss, Tinnitus And Pineal Germinoma: Parinaud Dorsal Midbrain Syndrome Revisited</h3></a>
500				
501                <p>
502				Rithvik Marri<sup>1</sup>, Harini Rao<sup>2</sup>, [....]                
503                </p>
504                  <ul class="infolinks">
505              
506				<li><a href="https://www.oncogen.org/full-text/hearing-loss-tinnitus-and-pineal-germinoma-parinaud-dorsal-midbrain-syndrome-revisited" target="_blank" title="Hearing Loss, Tinnitus And Pineal Germinoma: Parinaud Dorsal Midbrain Syndrome Revisited"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
507                
508                    
509                    
510                        <li>
511                <a href="https://www.oncogen.org/full-text/hearing-loss-tinnitus-and-pineal-germinoma-parinaud-dorsal-midbrain-syndrome-revisited" target="_blank" title="Hearing Loss, Tinnitus And Pineal Germinoma: Parinaud Dorsal Midbrain Syndrome Revisited" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
512                </li>
513                    
514                        
515                    
516               
517                </ul>
518				</div>
519				</div>
520                				<div class="col-md-6">
521				<div class="journalarticles fix_height">
522                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
523		
524				<a href="https://www.oncogen.org/full-text/chromatographic-fractionation-of-an-ethanolic-extract-of-peels-from-ipomoea-batatas-lam-for-improved-anticancer-activity" target="_blank" title="Chromatographic Fractionation of An Ethanolic Extract of Peels from Ipomoea batatas Lam for Improved Anticancer Activity"><h3>Chromatographic Fractionation of An Ethanolic Extract of Peels from Ipomoea batatas Lam for Improved Anticancer Activity</h3></a>
525				
526                <p>
527				Oluyori Abimbola P.<sup>1*</sup>, Olatunji Gabriel [....]                
528                </p>
529                  <ul class="infolinks">
530              
531				<li><a href="https://www.oncogen.org/full-text/chromatographic-fractionation-of-an-ethanolic-extract-of-peels-from-ipomoea-batatas-lam-for-improved-anticancer-activity" target="_blank" title="Chromatographic Fractionation of An Ethanolic Extract of Peels from Ipomoea batatas Lam for Improved Anticancer Activity"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
532                
533                    
534                    
535                        <li>
536                <a href="https://www.oncogen.org/full-text/chromatographic-fractionation-of-an-ethanolic-extract-of-peels-from-ipomoea-batatas-lam-for-improved-anticancer-activity" target="_blank" title="Chromatographic Fractionation of An Ethanolic Extract of Peels from Ipomoea batatas Lam for Improved Anticancer Activity" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
537                </li>
538                    
539                        
540                    
541               
542                </ul>
543				</div>
544				</div>
545                				<div class="col-md-6">
546				<div class="journalarticles fix_height">
547                <div class="btn btn-sm btn-default m-b-10">Case Report</div>
548		
549				<a href="https://www.oncogen.org/full-text/primary-renal-lymphoma-a-case-report" target="_blank" title="Primary Renal Lymphoma: A Case Report"><h3>Primary Renal Lymphoma: A Case Report</h3></a>
550				
551                <p>
552				Mohammed Alagha<sup>1*</sup>, Ramadan Algamal<sup> [....]                
553                </p>
554                  <ul class="infolinks">
555              
556				<li><a href="https://www.oncogen.org/full-text/primary-renal-lymphoma-a-case-report" target="_blank" title="Primary Renal Lymphoma: A Case Report"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
557                
558                    
559                    
560                        <li>
561                <a href="https://www.oncogen.org/full-text/primary-renal-lymphoma-a-case-report" target="_blank" title="Primary Renal Lymphoma: A Case Report" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
562                </li>
563                    
564                        
565                    
566               
567                </ul>
568				</div>
569				</div>
570                				<div class="col-md-6">
571				<div class="journalarticles fix_height">
572                <div class="btn btn-sm btn-default m-b-10">Research Article</div>
573		
574				<a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="The Importance of Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Raman Biospectroscopy of Single-Walled Carbon Nanotubes (SWCNT) and Multi-Walled Carbon Nanotubes (MWCNT) in Interpreting Infrared and Raman Spectra of Human Cancer Cells, Tissues and Tumors"><h3>The Importance of Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Raman Biospectroscopy of Single-Walled Carbon Nanotubes (SWCNT) and Multi-Walled Carbon Nanotubes (MWCNT) in Interpreting [....]</h3></a>
575				
576                <p>
577				Elise F Nassif*, Alexandre Arsene-Henry, Youlia M  [....]                
578                </p>
579                  <ul class="infolinks">
580              
581				<li><a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="The Importance of Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Raman Biospectroscopy of Single-Walled Carbon Nanotubes (SWCNT) and Multi-Walled Carbon Nanotubes (MWCNT) in Interpreting Infrared and Raman Spectra of Human Cancer Cells, Tissues and Tumors"><i class="fa fa-file-text" aria-hidden="true"></i>Full-Text</a></li>
582                
583                    
584                    
585                        <li>
586                <a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="The Importance of Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Raman Biospectroscopy of Single-Walled Carbon Nanotubes (SWCNT) and Multi-Walled Carbon Nanotubes (MWCNT) in Interpreting Infrared and Raman Spectra of Human Cancer Cells, Tissues and Tumors" ><i class="fa fa-file-pdf-o" aria-hidden="true"></i>PDF</a>
587                </li>
588                    
589                        
590                    
591               
592                </ul>
593				</div>
594				</div>
595                				
596			
597				
598				</div>
599				<!-- articles end -->
600                
601                
602        	</div>
603         
604            
605     </div> <!-- col-md-9 end -->
606	
607		<!-- Right section --> 
608        <!-- col-md-3 start -->
609         <div class="col-md-3">
610
611				<!-- current issues start-->
612				<div class="journalarticlesheading m-t-40">
613				<h3>Current Issues</h3>
614				</div>
615				<div class="currentissues m-t-20 m-b-40">
616                
617                                            <div class="currentissuescontent">
618				<h4><a href="https://www.oncogen.org/full-text/cognitive-impairment-secondary-to-treatment-of-cured-brain-metastases-of-triple-negative-breast-carcinoma" target="_blank" title="Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma">Cognitive Impairment Secondary To Treatment Of Cured Brain Metastases Of Triple-Negative Breast Carcinoma</a></h4>
619           
620				</div>
621				                            <div class="currentissuescontent">
622				<h4><a href="https://www.oncogen.org/full-text/post-translational-modifications-ptms-from-a-cancer-perspective-an-overview" target="_blank" title="Post-translational Modifications (PTMs), from a Cancer Perspective: An Overview">Post-translational Modifications (PTMs), from a Cancer Perspective: An Overview</a></h4>
623           
624				</div>
625				                            <div class="currentissuescontent">
626				<h4><a href="https://www.oncogen.org/full-text/the-suppression-of-prolactin-is-required-for-the-treatment-of-advanced-prostate-cancer" target="_blank" title="The Suppression of Prolactin is required for the Treatment of Advanced Prostate Cancer">The Suppression of Prolactin is required for the Treatment of Advanced Prostate Cancer</a></h4>
627           
628				</div>
629				                            <div class="currentissuescontent">
630				<h4><a href="https://www.oncogen.org/full-text/palliative-systemic-treatment-of-advanced-merkel-cell-carcinoma-in-the-pre-immunotherapy-era-a-retrospective-single-center-analysis-of-patients-with-an-orphan-neuroendocrine-malignancy" target="_blank" title="Palliative Systemic Treatment of Advanced Merkel Cell Carcinoma in the Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis of Patients with An Orphan Neuroendocrine Malignancy">Palliative Systemic Treatment of Advanced Merkel Cell Carcinoma in the Pre-Immunotherapy Era: A Retrospective, Single-Center Analysis of Patients with An Orphan Neuroendocrine Malignancy</a></h4>
631           
632				</div>
633				                            <div class="currentissuescontent">
634				<h4><a href="https://www.oncogen.org/full-text/crispr-cas9-based-editing-of-cdk4-p107-and-tgf-1-in-human-breast-and-lung-cancer-cells" target="_blank" title="CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells">CRISPR/Cas9-based Editing of CDK4, p107, and TGFβ1 in Human Breast and Lung Cancer Cells</a></h4>
635           
636				</div>
637								
638				
639			
640				
641				
642				</div>
643				<!-- current issues end-->
644				
645				<!-- latest tweets start-->
646				<!-- latest tweets start-->
647				<div class="journalarticlesheading">
648				<h3>Latest Tweets</h3>
649				</div>
650				
651				<div class="latesttweets m-t-20 m-b-40">
652				<a class="twitter-timeline" data-theme="" data-height="600" data-link-color="" href="https://twitter.com/MagnusMedClub?ref_src=twsrc%5Etfw">Tweets by CatalysisEvent</a> 
652<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
652
653				</div>
654				<!-- latest tweets end-->
655				
656			
657				
658				
659				
660				<!-- Subscribe start-->
661				<div class="journalarticlesheading">
662				    <h3>Subscribe</h3>
663				</div>
664				<div class="Subscribe m-t-20">
665				<h6>Subscribe to our email newsletter</h6>
666				
667				<div class="subscribesec">
668              
669                 
670                 <form class="widget-subscribe-form ram" id="subscribe_form" method="post" autocomplete="off">
671                        
672                            <div class="row">
673                                <div class="col-md-12">
674                                    <div class="form-group">
675                                       
676                                        <label class="upper text-left" for="name">  Email address:  </label>
677                                        <label for="subscribe_email" class="error" id="subscribe_email-error" style="display:none;"> </label>
678                                        <input type="email" aria-required="true" name="subscribe_email" class="required email" placeholder="Enter your Email">    
679                                    </div>
680                                </div>        
681                            </div>
682                            
683
684                            
685                            <div class="row">
686                                <div class="col-md-12">
687                    			    <div class="form-group">
688                    				    <label class="upper text-left" for="name"> Enter Captcha: </label>
689                    					<input type="text" class="form-control required" name="sub_captchcode" placeholder="Enter Answer" id="sub_captchcode" aria-required="true">
690                                    </div>
691                                </div>
692                            </div>
693                            
694                            <div class="row">
695                                <div class="col-md-12" id="cap-img">
696            					    <div class="form-group">
697            					        <label class="upper text-left" for="name"> Captcha Code:  </label>
698            					        <div class="clear">
699            					            <div class="pull-left">
700                                                <img src="" class="captcha-img"  alt="Antispam Code">
701                                            </div>    
702                                            <div class="pull-left">
703                                                <a title="reload" class="reload-captcha" href="javascript:relod();" >
704                                                  <i class="fa fa-refresh fa-3" aria-hidden="true"></i>
705                                                </a>
706                                            </div>
707                                            <a title="reload" class="reload-captcha" href="javascript:relod();" >Generate&nbsp;new&nbsp;code</a> 
708                                        </div>
709                                    </div>
710                                </div> 
711                            </div>    
712                            
713                            
714                            <div class="row">
715                                <div class="col-md-12">
716                                    <button class="btn btn-lg btn-full" type="submit">Subscribe</button>
717                                </div>        
718                            </div>             
719        
720                    </form>
721				</div>
722				</div>
723				
724				 
725				<!-- Subscribe end-->
726				
727				
728				
729			</div>            
730            <!-- col-md-3 end -->
731			
732		
733		</div>
734	</div>
735    <!--end container end-->
736    
737    
738        
739        
740        
741    <div class="footer">
742		<div class="container">
743			<div class="row">
744    			<div class="col-md-4 footersupport">
745                    <div class="m-b-40">
746        			    <h3>Address</h3>
747            			<p><i class="fa fa-university" aria-hidden="true"></i><strong>Magnus Med Club</strong></p>
748            			<p><i class="fa fa-map-marker" aria-hidden="true"></i>  8408 Gradington Drive, 
749            			<br>Westerville, OH 43081, USA</p>
750            			<p><i class="fa fa-phone" aria-hidden="true"></i>+1 614-826-7766</p>
751            			<p><i class="fa fa-envelope" aria-hidden="true"></i><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2e4d41405a4f4d5a6e434f49405b5d434b4a4d425b4c004d4143">[email&#160;protected]</a></p>
752        			</div>
753        			<div class="">
754        			    <h4>Stay Connected</h4>
755            			<div class="socialmedia1">
756            				<ul>
757            				<li>
758            				<a href="https://www.facebook.com" title="Face Book" target="_blank"><div class="facebook">
759            				<i class="fa fa-facebook" aria-hidden="true"></i><br>
760            				</div></a>
761            				</li>
762            				<li>
763            				<a href="https://x.com/magnus_med1203" title="Twitter" target="_blank"><div class="twitter">
764            				<i class="fa fa-twitter" aria-hidden="true"></i><br>
765            				</div></a>
766            				</li>
767            				<li>
768            				<a href="https://plus.google.com/" title="Google+" target="_blank"><div class="googleplus">
769            				<i class="fa fa-google" aria-hidden="true"></i><br>
770            				</div></a>
771            				</li>
772            				<li>
773            				<a href="https://www.magnusmedclub.com/" title="RSS Feeds" target="_blank"><div class="rss">
774            				<i class="fa fa-rss" aria-hidden="true"></i><br>
775            				</div></a>
776            				</li>
777            				</ul>
778            			</div>
779        			</div>    
780    			</div>
781    			            
782    			<div class="col-md-4 footersupport">
783                
784                
785    			<h4>Quick Links</h4>
786    			<div class="row">
787                                                 
788                                        
789    			<div class="col-md-12 col-xs-12">
790    			<ul>
791                    			<li><a href="https://www.magnusmedclub.com/plagarism#pl4" title="Peer-Review Process" target="_blank" >Peer-Review Process</a></li>
792    			
793                    			<li><a href="https://www.magnusmedclub.com/plagarism#pl5" title="Article Process Charges" target="_blank" >Article Process Charges</a></li>
794    			
795                    			<li><a href="https://www.magnusmedclub.com/plagarism#pl1" title="Plagarism" target="_blank" >Plagarism</a></li>
796    			
797                    			<li><a href="https://www.magnusmedclub.com/plagarism#pl2" title="Open Access Policy" target="_blank" >Open Access Policy</a></li>
798    			
799                    			<li><a href="https://www.magnusmedclub.com/plagarism#pl3" title="Publication Ethics" target="_blank" >Publication Ethics</a></li>
800    			
801                    			</ul>
802    			</div>
803    			       			</div>
804    			</div>
805                
806                <div class="col-md-4 footersupport">
807    			<h3>Quick Contact</h3>
808    					<form class="widget-subscribe-form" id="signup_form"  method="post">
809    					    <div class="row">
810								<div class="col-md-6">
811								    <div class="form-group">
812                                        <label class="text-white">Name</label>
813                                        <input type="text" aria-required="true" name="q_name" class="form-control required" placeholder="Name">
814                                    </div>    
815								</div>    
816      									    
817      							<div class="col-md-6">
818      							    <div class="form-group">
819                                        <label class="text-white">Email address</label>
820                                        <input type="email" aria-required="true" name="q_email" class="form-control required" placeholder="Your Email address">
821                                    </div>
822      							</div>    		    
823      						</div>			    
824                            
825                            <div class="row">
826                                <div class="col-md-12">
827                                <div class="form-group">
828                                    <label for="" class="text-white">Message</label>
829                                    <textarea class="form-control" name="q_message" rows="2" placeholder="Message"></textarea>
830                                </div>
831                                </div>
832                            </div>    
833                            
834                            
835                            
836                            <div class="row">
837                                    
838      									<div class="col-md-6">
839                                            <div class="form-group">
840                                    <label class="text-white" for="captchcode_sign">Enter Captcha <span class="span">*</span>: </label>									
841                                    <input type="text" class="form-control required" name="captchcode_q" placeholder="Enter Captch Code" id="captchcode_q" aria-required="true">                                  
842                                                               <label for="captchcode_q" class="error" id="captchcode_q-error" style="display:none;"></label>
843                                            </div>
844    									</div>
845      									<div class="col-md-6">
846                                            <div class="form-group">
847                                                <label class="text-white" >Captcha Code: </label>							
848                                                <div class="cpatcha-box-1"> 
849                                                    <div class="pull-left">
850               										    <img src="https://magnusmedclub.com/assets-front/img/captch-img.jpg" class="captcha-img" alt="Antispam Code">
851                                                    </div>
852                                                    <div class="pull-left">
853                                                      <a title="reload" class="reload-captcha" href="javascript:relod();" >
854                                                        <i class="fa fa-refresh fa-2" aria-hidden="true"></i>
855                                                        </a>
856                                                    </div>
857                                                    <span> <a title="reload" href="javascript:relod();" class="text-white">genrate new code</a> </span>
858           										</div>
859                                            </div>
860    									</div>
861                            </div>
862                            
863    						
864    						<button class="btn btn-lg btn-full" type="submit">Submit</button>
865                            
866                            </form>
867                            <div class="m-t-0 m-l-10 m-r-10 center">
868                                        <div class="col-md-12" id="q_success"></div>
869                                   		 </div>
870    			</div>
871			</div>
872			<!-- <hr>
873			<p>Copyright © 2018 Magnus Med Club Ltd. All rights reserved.</p> -->
874		</div>
875	</div>
876			
877			<div class="footerbottom">
878			<div class="container">
879			<div class="row">
880			<div class="col-md-12">
881			
882			<p>© Copyright 2018 Magnus Med Club Ltd. All Rights Reserved.  </p>
883			</div>
884			</div>
885			</div>
886			</div>
887
888    <div class='scrolltop'>
889    <div class='scroll icon'><i class="fa fa-4x fa-angle-up"></i></div>
890</div>
891
892
893<a href="javascript:avoid;" rel="nofollow" id="goToTop" class="cd-top js-cd-top cd-top--fade-out cd-top--show"><i class="fa fa-angle-up"></i></a>
894    <!-- Go to top button -->
895            
896
897    <!--Plugins-->
vendor: 114 bytes, lines 897-898
897
898    <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script>
898<script src="https://magnusmedclub.com/assets-front/js/jquery.js"></script>
898
899    
899<script src="https://magnusmedclub.com/assets-front/js/plugins.js"></script>
899
900    <!--Template functions-->
901    
901<script src="https://magnusmedclub.com/assets-front/js/functions.js"></script>
901
902    
903        
904    <!-- Live Chat functions-->   
905<script type="text/javascript">function add_chatinline(){var hccid=93006337;var nt=document.createElement("script");nt.async=true;nt.src="https://mylivechat.com/chatinline.aspx?hccid="+hccid;var ct=document.getElementsByTagName("script")[0];ct.parentNode.insertBefore(nt,ct);}
906
907add_chatinline(); </script>
907
908
909 <!-- WhatsUp functions-->  
910 <!-- 
910<script src="https://app.wabi-app.com/widget/js/wabi.js?phone_number=+15407091879&lang=en&position=left"></script>
910-->  
911
912
913   
914
915
916
917<script>
918			$("#subscribe_form").submit(function(){
919				
920				var data=$(this).serialize();
921					$.ajax({
922    type: 'POST',
923    url: "https://magnusmedclub.com/subscribers",
924    data: data,   
925	dataType: 'json',
926    beforeSend: function() {
927		
928        // setting a timeout
929       // $(placeholder).addClass('loading');
930       },
931    success: function(msg) {
932		//alert();
933	 //console.log('Data:', msg);
934	 
935	 if(msg['status']=='error'){
936		  $("#subscribe_email-error").fadeIn();
937		$("#subscribe_email-error").html(msg['msg']) ;
938	 }else{
939		 $("#subscribe_email-error").fadeIn();
940		 $("#subscribe_form")[0].reset();
941		 $("#subscribe_email-error").removeClass('error');
942		$("#subscribe_email-error").html(msg['msg']) ;
943		 $("#subscribe_email-error").fadeOut(6000);
944	 }
945    
946    },
947    
948
949   });
950		return false;
951				
952			});
953			
954			
955
956
957
958$("#signup_form").submit(function(){
959				
960				var data=$(this).serialize();
961	$.ajax({
962    type: 'POST',
963    url: "https://magnusmedclub.com/quickcontact",
964    data: data,   
965	dataType: 'json',
966    beforeSend: function(msg) {
967		//console.log('Data:', msg);
968        // setting a timeout
969       // $(placeholder).addClass('loading');
970       },
971    success: function(msg) {
972		
973	 //console.log('Data:', msg);
974	 var mid=msg['id'];
975	 var id='#'+mid+'-error';
976	 if(msg['status']=='error'){
977		  $(id).show();
978		$(id).html(msg['msg']) ;
979		$("input[name="+mid+"]").focus();
980	 }else{
981		 $("#"+mid).fadeIn();
982		 $("#signup_form")[0].reset();
983		$("#"+mid).html(msg['msg']) ;
984		 $("#"+mid).fadeOut(6000);
985	 }
986    
987    },
988    
989
990   });
991		return false;
992				
993			});
994			
995			</script>
995
996            
997    
997<script src="https://magnusmedclub.com/assets-admin/js/plugins/jquery.validate.min.js" type="text/javascript"></script>
997
998 
998<script type="text/javascript">
999    function setFormValidation(id) {
1000        $(id).validate({
1001            highlight: function(element) {
1002                $(element).closest('.form-group').removeClass('has-success').addClass('has-error');
1003                $(element).closest('.form-check').removeClass('has-success').addClass('has-error');
1004            },
1005            success: function(element) {
1006                $(element).closest('.form-group').removeClass('has-error').addClass('has-success');
1007                $(element).closest('.form-check').removeClass('has-error').addClass('has-success');
1008            },
1009            errorPlacement: function(error, element) {
1010                $(element).closest('.form-group').append(error).addClass('has-error');
1011            },
1012        });
1013    }
1014
1015    $(document).ready(function() {
1016		
1017        setFormValidation('#signup_form');
1018       
1019    });
1020</script>
1020
1021
1022<script>
1023$(function(){
1024	relod();
1025
1026});
1027
1028 function relod(){
1029      //alert();
1030        $.ajax({
1031           url:'https://magnusmedclub.com/new-captcha',
1032           success:function(data){
1033              $('.captcha-img').attr('src', data);
1034           }
1035        });            
1036   }
1037</script>
1037    
1038    
1039<script type="module" src="https://static.cloudflareinsights.com/beacon.min.js/v4bc70e2c01a94c73b74392e4234840661791215815920" integrity="sha512-L0ha0OXavK/8okipN9F8BtP84dg9DUhPERbBXzwI6dgTA55d2+yweo3pn5CSFYs45/r8md2+xvUPtTdvTNRfjA==" data-cf-beacon='{"version":"2024.11.0","token":"5d191fcba85540908275da72fc03ef9c","r":1,"spa":2}' crossorigin="anonymous"></script>
1039
1040</body>
1041</html>

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.